CRINETICS PHARMACEUTIC

Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

11 сен 2023 15:01:22 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

11 сен 2023 05:00:48 Источник Nasdaq GlobeNewswire

Crinetics’ Once-Daily Oral Paltusotine Achieved the Primary and All Secondary Endpoints in the Phase 3 PATHFNDR-1 Study Evaluating Treatment of Patients with Acromegaly

10 сен 2023 09:00:04 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 авг 2023 16:34:32 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Corporate Update

08 авг 2023 06:00:01 Источник Nasdaq GlobeNewswire

Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly

31 июл 2023 07:01:44 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 июл 2023 15:19:04 Источник Nasdaq GlobeNewswire

New Data Demonstrating Stable Biochemical and Symptom Levels with Two-Years of Oral Paltusotine Administration Presented at ENDO 2023

21 июн 2023 06:59:39 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 июн 2023 06:30:09 Источник Nasdaq GlobeNewswire

Crinetics to Highlight Broad Pipeline at ENDO 2023

09 июн 2023 06:30:08 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 май 2023 15:21:55 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

04 май 2023 15:05:12 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 апр 2023 15:31:01 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 мар 2023 15:37:50 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update

28 фев 2023 15:05:39 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 фев 2023 16:21:42 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Participate in the SVB Securities Global Biopharma Conference

10 фев 2023 07:01:33 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

10 янв 2023 15:48:48 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

09 янв 2023 07:01:39 Источник Nasdaq GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

12 дек 2022 15:01:00 Источник Nasdaq GlobeNewswire